Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Bone Marrow Transplantation
100%
Hematopoietic Stem Cell Transplantation
92%
Fas Ligand
84%
Hematopoietic Stem Cells
78%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
73%
Marrow Transplantation
70%
Blood Transplantation
70%
Apoptosis
67%
Neuroblastoma
58%
European Society
57%
Graft-versus-host Disease (GvHD)
54%
Overall Survival
51%
Israel
51%
Transplantation
51%
Stem Cell Transplantation
50%
Bone Marrow
47%
T Cells
47%
Autoimmunity
46%
Engraftment
44%
Working Party
41%
Event-free Survival
38%
Hematopoietic Cells
38%
Allogeneic Bone Marrow Transplantation
37%
Pediatric
37%
Chronic Graft-versus-host Disease (cGVHD)
37%
Conditioning Regimen
37%
Tumor
36%
NOD Mice
34%
Immunomodulation
34%
Busulfan
32%
Pediatric Hematopoietic Stem Cell Transplantation
32%
Cell Engraftment
32%
Childhood Acute Lymphoblastic Leukemia
30%
Stem Cells
29%
Donor Cells
29%
Nave
28%
Treosulfan
27%
Peripheral Blood Stem Cells
27%
Neogenesis
26%
Chemotherapy
26%
Cord Blood Transplantation
26%
Treg
26%
Peripheral Blood Stem Cell Collection
26%
Bone Marrow Cells
25%
Supportive Care
25%
Acute Myeloid Leukemia
25%
Myeloablative Conditioning
25%
Reduced-intensity Conditioning
25%
Diabetes
25%
Autoimmune Diabetes
25%
Medicine and Dentistry
Pediatrics
97%
Hematopoietic Stem Cell Transplantation
93%
Bone Marrow Transplantation
82%
Diseases
64%
Allogeneic Hematopoietic Stem Cell Transplantation
61%
Overall Survival
59%
Fas Ligand
57%
Hematopoietic Cell
55%
Engraftment
48%
Graft Versus Host Reaction
46%
Chemotherapy
41%
Acute Myeloid Leukemia
41%
Stem Cell Therapy
40%
Cord Blood
34%
Ganglioneuroblastoma
34%
Adolescence
33%
Cord Blood Stem Cell Transplantation
32%
Programmed Cell Death
32%
Myelodysplastic Syndrome
29%
Stem Cell
28%
Peripheral Blood Stem Cell
27%
Event Free Survival
26%
Supportive Care
25%
Tumor
25%
Reduced Intensity Conditioning
25%
Childhood Cancer
24%
Ewing Sarcoma
24%
Pediatric Disease
24%
Aplastic Anemia
24%
Malignant Neoplasm
24%
Infection
23%
Oncology
22%
Intensive Care Unit
20%
Graft Failure
19%
Busulfan
19%
Intensive Care
19%
Myeloablative Conditioning
19%
Autoimmunity
19%
Disease Free Survival
19%
Allogenic Bone Marrow Transplantation
19%
Immunomodulation
18%
Treosulfan
18%
Sepsis
18%
Median Follow Up
18%
Leukemia
17%
Minimal Residual Disease
17%
Vein Occlusion
17%
Survival Rate
17%
Whole Body Radiation
16%
Psychopharmacology
16%
Immunology and Microbiology
Programmed Cell Death
82%
Fas Ligand
73%
Graft-Versus-Host Disease
63%
Engraftment
62%
Stem Cell
60%
Bone Marrow Transplantation
59%
T Cell
57%
Hematopoietic Cell
55%
Hematopoietic Stem Cell Transplantation
55%
Autoimmunity
55%
Umbilical Cord Blood
44%
Cord Blood Stem Cell Transplantation
41%
Nonobese Diabetic Mouse
41%
Regulatory T Cell
38%
Overall Survival
37%
Bone Marrow Cell
34%
Allogeneic Hematopoietic Stem Cell Transplantation
32%
Immunomodulation
32%
Tumor Necrosis Factor Receptor
28%
Allogeneic Bone Marrow Transplantation
27%
Lineages
27%
Acute Graft Versus Host Disease
25%
Insulin
24%
Tumor Necrosis Factor
24%
Autoimmune Diabetes
23%
CD34
22%
Lymphocyte
21%
Fas Receptor
21%
Disease Free Survival
20%
Syngenic
20%
Homeostasis
19%
Cytokine
19%
Event Free Survival
19%
CD25
18%
Severe Combined Immunodeficiency
18%
Caspase
17%
Survival Rate
16%
Myeloid
16%
B Cell
16%
Hemophagocytic Lymphohistiocytosis
16%
Cell Death
16%
Haplotype
16%
Mesenchymal Stem Cell
16%
Dendritic Cell
16%
Wiskott-Aldrich Syndrome
16%
CD4
14%
Cyclophosphamide
14%
Steroid
13%
Lymph Node
12%
Peripheral Blood Stem Cell
12%